| DRL | dorsal root, lumbar; drug-related lupus |
|---|---|
| DRMS | drug reaction monitoring system |
| DS | dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul... |
| DUE | drug use evaluation |
| DUF | Doppler ultrasonic flowmeter; drug use forecast |
| drug-induced immune hemolytic a. |
immune hemolytic anemia induced by drugs, classified by mechanism as penicillin type, in which the drug, acting as a hapten bound to the red cell membrane, induces the formation of specific antibodies; methyldopa type, in which the drug, possibly by inhibition of suppressor T cells, induces the formation of anti-Rh antibodies; or stibophen or “innocent bystander” type, in which circulating drug-antibody immune complexes bind nonspecifically to red cells. The first two types usually involve warm-reactive antibodies and accelerated sequestration of red cells by the reticuloendothelial system; the third usually involves cold-reactive antibodies and complement-dependent intravascular hemolysis.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|---|
| drug-induced l. |
a syndrome similar to systemic lupus erythematosus, caused by any of various drugs, such as hydralazine, procainamide, isoniazid, D-penicillamine, and chlorpromazine; it usually resolves following withdrawal of the offending drug.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| drug-induced n. |
that caused by medications; the most common mechanisms are immunological (formation of antibodies destructive to neutrophils or of immune complexes that bind to neutrophils), followed by inhibition of granulopoiesis and direct damage to bone marrow or precursor cells of the granulocytic series.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| drug resistance |
Normal or tumor cells that are able to survive when exposed to a variety of drugs. Top of page
Ãâó: www.rationaltherapeutics.com/reference/glossary.ht...
|
| Drug Abuse Warning Network |
ABBR: DAWN. A system for obtaining statistical data concerning admission to a sample of emergency treatment facilities for drug abuse.
Ãâó:
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|